Healing of a Large Long-Bone Defect through Serum-Free In Vitro Priming of Human Periosteum-Derived Cells.
Healing of a Large Long-Bone Defect through Serum-Free In Vitro Priming of Human Periosteum-Derived Cells.
复制标题
DOI:
10.1016/j.stemcr.2017.01.005
复制
发表时间:
2017-03-14
影响因子:
5.9
通讯作者:
Luyten FP
中科院分区:
文献类型:
--
作者:
Bolander J;Ji W;Leijten J;Teixeira LM;Bloemen V;Lambrechts D;Chaklader M;Luyten FP
Clinical translation of cell-based strategies for regenerative medicine demands predictable in vivo performance where the use of sera during in vitro preparation inherently limits the efficacy and reproducibility. Here, we present a bioinspired approach by serum-free pre-conditioning of human periosteum-derived cells, followed by their assembly into microaggregates simultaneously primed with bone morphogenetic protein 2 (BMP-2). Pre-conditioning resulted in a more potent progenitor cell population, while aggregation induced osteochondrogenic differentiation, further enhanced by BMP-2 stimulation. Ectopic implantation displayed a cascade of events that closely resembled the natural endochondral process resulting in bone ossicle formation. Assessment in a critical size long-bone defect in immunodeficient mice demonstrated successful bridging of the defect within 4 weeks, with active contribution of the implanted cells. In short, the presented serum-free process represents a biomimetic strategy, resulting in a cartilage tissue intermediate that, upon implantation, robustly leads to the healing of a large long-bone defect. Serum-free pre-conditioning affects the identity of periosteal progenitor cells A reduced CD105+, elevated CD34+, and upregulated BMP receptor expression was seen Priming by aggregation and BMP stimulation induced endochondral bone formation Validation in a critical size fracture model confirmed endochondral healing The use of sera in the preparation of cell-based strategies critically limits the efficacy and reproducibility of the process as it conflicts with cellular responses. Luyten and colleagues present a bioinspired engineering process including serum-free pre-conditioning combined with micro-aggregation and bone morphogenetic protein priming resulting in a self-sustained tissue intermediate that, upon implantation, successfully heals critical long-bone defects.